Showing results (21-30 of 2,434) with videos related to
Sort By:
Pageof 244
Clinical and Translational Science|June 16, 2022
Going beyond bibliometrics: A system to track the progress and impact of biomedical research funded by Susan G. KomenAmy M Dworkin, Stephanie Reffey, Kari WojtanikClinical and Translational Science|May 6, 2022
Influence of CYP2D6 genetic variation on adverse events with propafenone in the pediatric and young adult populationSudeep D Sunthankar, Prince J Kannankeril, Andrea Gaedigk, et al.Clinical and Translational Science|June 22, 2021
Lipid droplet screen in human hepatocytes identifies TRRAP as a regulator of cellular triglyceride metabolismDeepti Abbey, Donna Conlon, Christopher Rainville, et al.Clinical and Translational Science|January 5, 2023
CARE program: NCI and FDA interagency collaborations to support oncology small business entrepreneursMonique A Pond, Deepa Narayanan, Kehui Zhang, et al.Clinical and Translational Science|January 16, 2023
Clinical assessment of gepotidacin (GSK2140944) as a victim and perpetrator of drug-drug interactions via CYP3A metabolism and transportersAline Barth, Caroline R Perry, Shaila Shabbir, et al.Clinical and Translational Science|December 27, 2022
Pharmacokinetics, pharmacodynamics, safety and tolerability of cilofexor, a novel nonsteroidal Farnesoid X receptor agonist, in healthy volunteersIslam R Younis, Brian J Kirby, Andrew N Billin, et al.Clinical and Translational Science|June 9, 2022
A randomized, placebo-controlled study to evaluate safety and pharmacokinetics of inhaled ribavirinPeter Couroux, Alexandre Brkovic, Jason L Vittitow, et al.Clinical and Translational Science|June 29, 2022
Rituximab pediatric drug development: Pharmacokinetic and pharmacodynamic modeling to inform regulatory approval for rituximab treatment in patients with granulomatosis with polyangiitis or microscopic polyangiitisCandice Jamois, Leonid Gibiansky, Clarisse Chavanne, et al.Clinical and Translational Science|June 20, 2022
Alternatives to rifampicin: A review and perspectives on the choice of strong CYP3A inducers for clinical drug-drug interaction studiesJayaprakasam Bolleddula, Sathej Gopalakrishnan, Ping Hu, et al.Clinical and Translational Science|May 4, 2022
PF-07321332 (Nirmatrelvir) does not interact with human ENT1 or ENT2: Implications for COVID-19 patientsRaymond K Hau, Stephen H Wright, Nathan J CherringtonPageof 244